{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:50Z","timestamp":1753891070226,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103427"],"award-info":[{"award-number":["P20GM103427"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["272201600038C"],"award-info":[{"award-number":["272201600038C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The host complement system is a critical component of innate immunity and serves as a principal mechanism of pathogen defense in mammals. EP67 is an engineered decapeptide derived from the C terminus of human complement protein C5a, which displays selective immunostimulatory activity. EP67 preferentially activates phagocyte mononuclear cells but shows minimal activity towards inflammatory granulocytes, including neutrophils. Previous studies of viral infection showed that EP67 possessed antiviral efficacy when used following infection and enhanced antibody responses to antigen challenges when used as an adjuvant. Here, we show in a rodent model that immunization with inactivated \u03b3-irradiated SARS-CoV-2 in combination with EP67 can produce elevated nucleocapsid-specific IgG antibodies compared to viral lysate alone, supporting an enhanced adaptive immune response. Additionally, intranasal administration of EP67 following infection with live MHV-A59 coronavirus resulted in a rapid health improvement in symptomatic infections compared to PBS vehicle controls. Taken together, these results suggest EP67 shows efficacy towards betacoronaviruses when used as an adjuvant during immunization or as a therapeutic during active infections. Moreover, these findings continue to support the capability of EP67 as an antiviral agent and a useful immunostimulatory peptide.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1470034","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:55:56Z","timestamp":1743767756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A selective C5a-derived peptidomimetic enhances IgG response following inactivated SARS-CoV-2 immunization and confers rapid disease resolution following murine coronavirus infection"],"prefix":"10.3389","volume":"16","author":[{"given":"Andrew J.","family":"Neville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackenzie E.","family":"Conrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas T.","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)38013-4","article-title":"Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a","volume":"253","author":"Fernandez","year":"1978","journal-title":"J Biol Chem"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.06.006","article-title":"Preliminary evidence that the novel host-derived immunostimulant ep67 can act as a mucosal adjuvant","volume":"161","author":"Karuturi","year":"2015","journal-title":"Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.0c00005","article-title":"Targeted amino acid substitution overcomes scale-up challenges with the human C5a-derived decapeptide immunostimulant ep67","volume":"6","author":"Alshammari","year":"2020","journal-title":"ACS Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.01.031","article-title":"A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells","volume":"8","author":"Hegde","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.029","article-title":"Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design","volume":"28","author":"Morgan","year":"2009","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01590-13","article-title":"A novel C5a-derived immunobiotic peptide reduces streptococcus agalactiae colonization through targeted bacterial killing","volume":"57","author":"Cavaco","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202348","article-title":"Targeting macrophage activation for the prevention and treatment of staphylococcus aureus biofilm infections","volume":"190","author":"Hanke","year":"2013","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040303","article-title":"Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a","volume":"7","author":"Sanderson","year":"2012","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01276-21","article-title":"A biosafety level 2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations","volume":"95","author":"Andrade","year":"2021","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.5.3097-3106.2005","article-title":"Recombinant mouse hepatitis virus strain A59 from cloned, full-length cdna replicates to high titers in vitro and is fully pathogenic in vivo","volume":"79","author":"Coley","year":"2005","journal-title":"J Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/v12080880","article-title":"Of mice and men: the coronavirus mhv and mouse models as a translational approach to understand sars-cov-2","volume":"12","author":"Korner","year":"2020","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12250-014-3530-y","article-title":"Coronavirus mhv-A59 infects the lung and causes severe pneumonia in C57bl\/6 mice","volume":"29","author":"Yang","year":"2014","journal-title":"Virol Sin"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01743-19","article-title":"Murine coronavirus infection activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent manner, contributing to cytokine modulation and proviral tcdd-inducible-parp expression","volume":"94","author":"Grunewald","year":"2020","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"Unit 15E 1","DOI":"10.1002\/9780471729259.mc15e01s21","article-title":"Coronaviruses: propagation, quantification, storage, and construction of recombinant mouse hepatitis virus","author":"Leibowitz","year":"2011","journal-title":"Curr Protoc Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/laban1005-39","article-title":"A rapid, simple, and humane method for submandibular bleeding of mice using a lancet","volume":"34","author":"Golde","year":"2005","journal-title":"Lab Anim (NY)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01122-w","article-title":"Sars-cov-2 immunity in animal models","volume":"21","author":"Chen","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3201\/eid2712.211621","article-title":"Postmortem stability of sars-cov-2 in mouse lung tissue","volume":"27","author":"Valkenburg","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.634839","article-title":"Vaping exacerbates coronavirus-related pulmonary infection in a murine model","volume":"12","author":"Sivaraman","year":"2021","journal-title":"Front Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-9373-7_24","article-title":"Mhv-A59 pathogenesis in mice","volume":"173","author":"Lavi","year":"1984","journal-title":"Adv Exp Med Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00922-20","article-title":"Descriptive, retrospective study of the clinical characteristics of asymptomatic covid-19 patients","volume":"5","author":"Han","year":"2020","journal-title":"mSphere"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of tnf-alpha and ifn-gamma triggers inflammatory cell death, tissue damage, and mortality in sars-cov-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1470034\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:55:59Z","timestamp":1743767759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1470034\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2025.1470034"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1470034","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1470034"}}